◼ Archived
Health
New weight-loss drug could give you a ‘flatter stomach’ in mere weeks
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Obesity Treatment
9 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
New research indicates nearly 17% of children using GLP-1 receptor agonists developed nutritional deficiencies within one year of treatment.
◼ Archived
Health
Can Obesity Treatment With GLP-1 Drugs Last Forever?
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
◼ Archived
Health
🔮 fades ✗
Experimental weight loss jab outperforms Mounjaro in latest study
A new experimental weight loss injection has outperformed Mounjaro in a recent study, signaling a potential shift in obesity treatment.
◼ Archived
Health
🔮 fades ✗
Lilly's weight-loss pill gets UK regulator's nod
The UK medicines regulator has approved a new once-daily weight-loss pill from Eli Lilly, offering an oral alternative to injectable GLP-1 treatments.
◼ Archived
Health
🔮 fades
New weight loss pill that’s beating oral Ozempic
A new oral GLP-1 receptor agonist is emerging as a potent weight-loss alternative, outperforming oral Ozempic in recent clinical trials.
◼ Archived
Health
🔮 fades
GLP-1 Therapies Silence Spontaneous Physical Activity
New evidence suggests combining structured exercise with GLP-1 therapies is essential for maximizing long-term health and economic value in obesity treatment.
◼ Archived
Health
🔮 fades
Ozempic Users Are Skimping Out on Exercise, Study Finds
New research indicates that patients taking GLP-1 weight loss drugs are reducing their physical activity levels.